Filing Details

Accession Number:
0001214659-21-012739
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-06 16:35:08
Reporting Period:
2021-12-02
Accepted Time:
2021-12-06 16:35:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581280 Twist Bioscience Corp TWST Biological Products, (No Disgnostic Substances) (2836) 462058888
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1755970 John Patrick Finn C/O Twist Bioscience Corporation
681 Gateway Blvd.
South San Francisco CA 94080
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-02 1,517 $26.66 39,751 No 4 M Direct
Common Stock Acquisiton 2021-12-02 241 $23.33 39,992 No 4 M Direct
Common Stock Disposition 2021-12-02 1,172 $87.06 38,820 No 4 S Direct
Common Stock Disposition 2021-12-02 586 $90.00 38,234 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2021-12-02 1,517 $0.00 1,517 $26.66
Common Stock Employee Stock Option (right to buy) Disposition 2021-12-02 241 $0.00 241 $23.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,891 2028-11-18 No 4 M Direct
20,204 2029-10-23 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 3, 2020.
  2. 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  3. 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.